Holmium chloride ho-166

Holmium-166 (¹⁶⁶Ho) is used in nuclear medicine to deliver targeted radiation for treating liver tumors, a procedure called radioembolization. It’s administered as radioactive microspheres injected directly into the tumor. ¹⁶⁶Ho is a beta and gamma emitter, allowing it to destroy cancer cells with its beta radiation while its gamma emissions provide real-time imaging for precise placement and monitoring. This dual function enables personalized, image-guided treatment for liver malignancies, offering a potentially curative, minimally invasive option. The directory classifies it as a under development API with a mineral/inorganic source/manufacturing origin. Other names for this substance include UNII-QVC0N62WQE and Holmium chloride (166HoCl3). Its PubChem CID is 72941737.

CAS No 183139-18-6
Molecular Formula Cl3Ho
Molecular Weight 272.29 g/mol
Synonyms holmium-166(3+);trichloride

Frequently Asked Questions